Approval · Notice of Compliance 15451 · 2014
MYCAMINE: Notice of Compliance 15451
Issued March 25, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15451
- Date
- March 25, 2014
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To include patient population age 4 months and over
- Therapeutic class
- Antifungal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYCAMINE | Not yet assigned | — |
Medicinal ingredients
- MICAFUNGIN SODIUM 50 MG per VIAL
- MICAFUNGIN SODIUM 100 MG per VIAL